Tirzepatide users in the SURMOUNT-1 trial lost up to 22.5% of body weight, substantially more than semaglutide STEP trial results
According to current recommendations, treatment intensification beyond metformin should be individualised based on patient factors including HbA1c levels, cardiovascular risk, presence of chronic kidney disease, heart failure, and patient preferences regarding weight management and hypoglycaemia risk
Iron Labs Nutrition is run by people who lift - we've been using our own products ever since the brand started and we know what works
Research labs report that administration errors increase exponentially beyond three peptides
We identify the specific activities and factors contributing to your condition, then develop personalized treatment plans
We conducted two new-user, active comparator cohort studies